Cutting-edge developments in blood-based biomarkers for Alzheimer’s; application in clinical trials
Julius Clinical and Amsterdam UMC are proud to present the webinar:
Cutting-edge developments in blood-based biomarkers for Alzheimer’s; application in clinical trials
During this webinar, Charlotte Teunissen, Professor in Neurochemistry at Amsterdam UMC touched upon:
- Patient selection
- Patient stratification
- Outcome measures
Related webinars
Webinar: Selecting and successfully integrating cognitive testing into clinical trials
On May 9, we presented the webinar: Selecting and successfully integrating cognitive testing into clinical trials During this webinar, hosted by Dr. Lieza Exalto, speaker Dr. John Harrison discussed: Cognitive domains – which ones sh...
Upcoming webinar: Real-World Data in ALS
We are excited to invite you to our webinar exploring the innovative integration of Real World Data (RWD) in clinical trials for Amyotrophic Lateral Sclerosis (ALS). As a critical step forward in the pursuit of effective treatments and improved pa...
Measuring and tracking everyday functioning in AD clinical trials with the Amsterdam IADL Questionnaire
In collaboration with our partner Brain Research Center, we presented the webinar: Measuring and tracking everyday functioning in AD clinical trials with the Amsterdam IADL Questionnaire Speakers: Dr. Sietske Sikkes | Associate Professor a...